Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Hematopoietic and Lymphatic System Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Hematopoietic and Lymphatic System Neoplasm

Cancer Family

Hematopoietic and Lymphatic System Neoplasm

CI-CAN-00000022Explore in graph →

Non-malignant4,304 active trials98 approved drugs1,010 evidence items

NCIt: C35813

Overview
Statistics
Survival
Genomics60
Variants & evidence1010
Drugs99
Trials18827
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (736)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 401–425 of 736 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
· Blood · 2013 · PMID 23086750 · validated civic_curation pubmed
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
· Blood · 2015 · PMID 26486786 · validated civic_curation pubmed
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
· Blood · 2016 · PMID 27288520 · validated civic_curation pubmed
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients.
· Leukemia · 2014 · PMID 24496303 · validated civic_curation pubmed
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
· N Engl J Med · 2016 · PMID 27355533 · validated civic_curation pubmed
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.
· Leukemia · 2016 · PMID 26464169 · validated civic_curation pubmed
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
· JAMA Oncol · 2015 · PMID 26182309 · validated civic_curation pubmed

Showing 401–425 of 736 publications

← Previous
1
…
16
17
18
…
30
Next →

CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia.

· Leukemia · 2006 · PMID 16307009 · validated civic_curation pubmed

The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.

· Clin Cancer Res · 2006 · PMID 17020971 · validated civic_curation pubmed

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

· Blood · 2009 · PMID 19779040 · validated civic_curation pubmed

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.

· J Clin Oncol · 2017 · PMID 28418267 · validated civic_curation pubmed

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.Retracted

· N Engl J Med · 2015 · PMID 26287849 · validated civic_curation pubmed

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

· Proc Natl Acad Sci U S A · 2010 · PMID 20018760 · validated civic_curation pubmed

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.

· Lancet Oncol · 2017 · PMID 28645776 · validated civic_curation pubmed

Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.

· Ann Hematol · 2017 · PMID 27815723 · validated civic_curation pubmed

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.

· J Clin Oncol · 2019 · PMID 31513482 · validated civic_curation pubmed

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

· Nat Genet · 2013 · PMID 23377183 · validated civic_curation pubmed

Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

· Nat Med · 2015 · PMID 25962120 · validated civic_curation pubmed

Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.

· Ann Med · 2019 · PMID 30592434 · validated civic_curation pubmed

Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.

· Blood · 2016 · PMID 26537301 · validated civic_curation pubmed

Characterization of leukemias with ETV6-ABL1 fusion.

· Haematologica · 2016 · PMID 27229714 · validated civic_curation pubmed

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.

· Lancet Haematol · 2021 · PMID 33357483 · validated civic_curation pubmed

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

· Blood · 2011 · PMID 21813447 · validated civic_curation pubmed

Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.

· Cancer Sci · 2021 · PMID 34159682 · validated civic_curation pubmed

EZH2 mutations are frequent and represent an early event in follicular lymphoma.

· Blood · 2013 · PMID 24052547 · validated civic_curation pubmed